Skip to content

Influence of Arm Retraction on the Supraclavicular Approach for Subclavian Vein Catheterization

Influence of Arm Retraction on the Relative Position of Clavicle and the Subclavian Vein,During Supraclavicular Approach for Central Venous Catheterization in Adults and Children

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02478749
Enrollment
60
Registered
2015-06-23
Start date
2015-05-31
Completion date
2015-07-31
Last updated
2016-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subclavian Venous Catheterization

Brief summary

The purpose of this study is to determine the effect of arm retraction on the supraclavicular approach for subclavian vein catheterization in adults and children.

Interventions

PROCEDUREarm retraction

gently pulling through the ipsilateral arm to the knee

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 60 Years
Healthy volunteers
No

Inclusion criteria

* patients undergoing general anesthesia regardless of subclavian venous catheterization

Exclusion criteria

* patients with infection over the puncture site history of thoracic surgery or clavicular fracture vascular malformation anatomical abnormality of subclavian vein

Design outcomes

Primary

MeasureTime frame
Change of distance between clavicle and confluence of internal jugular vein and subclavian vein while arm retractionOutcome measure will be assessed during arm retraction and it would be within 30 second of arm retraction
Change in diameter of suvclavian vein at the confluence of internal jugular vein and subclavian veinOutcome measure will be assessed during arm retraction and it would be within 30 second of arm retraction

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026